Discontinued — last reported Q3 '24

Business Segments · Indefinite-lived intangibles, gross carrying amount

Life Sciences — Indefinite-lived intangibles, gross carrying amount

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2024
Last reportedQ3 2024

How to read this metric

An increase typically reflects recent strategic acquisitions of established brands or intellectual property, while a decrease may indicate divestitures or impairment write-downs. Significant changes signal shifts in the segment's competitive positioning and the value of its acquired intangible portfolio.

Detailed definition

This metric represents the total gross book value of intangible assets within the Life Sciences segment that are determi...

Peer comparison

Peers in the life sciences and diagnostics sectors often report this as 'Indefinite-lived Intangible Assets' or 'Trademarks and Trade Names' within their segment-level intangible asset disclosures.

Metric ID: dhr_segment_life_sciences_indefinite_lived_intangibles_gross_carrying_amount

Historical Data

1 periods
 Q3 '24
Value$508.00M

Frequently Asked Questions

What is Danaher's life sciences — indefinite-lived intangibles, gross carrying amount?
Danaher (DHR) reported life sciences — indefinite-lived intangibles, gross carrying amount of $508.00M in Q3 2024.
What does life sciences — indefinite-lived intangibles, gross carrying amount mean?
The total historical cost of intangible assets like brands and trademarks in the Life Sciences segment that are not expected to expire.